iso9001 certification , page-7

Hi Anach.

Sounds like Mission Biotechnologies has been audited for its internal performance to perhaps fulfill obligations regarding the Valero Offtake Agreement - a thorough quality control accreditation in line with continuous improvement principles.

It provides further confidence but I'd like to know where they are going with their stated financing options that were hinted at on the 09/12/09.

Given that the first tranche of 81.41mn warrants will expire on the 31/08/10, and if fully exercised will provide MBT with $36.6m, shareholder approval is needed, therefore IMO, EGM reolutions must be coming.

As the first product shipment is expected to occur during the 2nd Q of calendar year 2010, it must be all hands on deck atm.